Dow keeps its use of animal testing to an absolute minimum. Animal testing is not something Dow undertakes arbitrarily, but neither is it something Dow can discontinue, as this testing plays a critical role in enhancing Dow’s understanding about the safety of Dow’s products, thereby protecting public health and the environment. Indeed, in almost all cases the laws of the countries in which Dow operates require such testing to be conducted.
Dow’s Predictive Toxicology Group is dedicated to finding and evaluating reliable alternatives to animal testing that meet Dow’s product stewardship requirements. Dow supports the 3R’s — reduce the use of animals, replace them with non-animal test methods, or refine test procedures to eliminate animals’ pain and distress. Dow has integrated alternative methods into their product safety evaluations where their use will not compromise human health or safety. Dow scientists actively promote acceptance of these methods to global regulatory agencies.
In addition, Dow has participated in the accreditation process promoted by Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International - a private, non-profit organization that promotes humane animal care and use in science, which is considered the gold standard of laboratory animal care programs. The Dow toxicology laboratory has been fully accredited by AAALAC since 1968 and expects any external laboratory Dow uses to comply with AAALAC or equivalent standards.